New Modality Support, or NMS in short, is a project coordinated by GU Ventures and based at GoCo Health Innovation City in Mölndal. The aim of the project is to facilitate scaling up individual research projects in the ATMP/Therapeutic Oligonucleotides arena. It supports business development and investments throughout the process, from research results and company formation to commercialization.

Participating partners
NMS is a cooperative project founded by CCRM Nordic, OligoNova, Sahlgrenska Academy at the University of Gothenburg, GU Ventures and the Sahlgrenska University Hospital.

Do you want to know more about NMS?
Please visit our website to learn more.

New Modality Support

Org chart

Teams

Offices